title: Reactivation of bovine tuberculosis in patient treated with infliximab, Switzerland.
authors.forename: Marina
authors.initials: M
authors.lastname: Nager
authors.forename: Philip E
authors.initials: PE
authors.lastname: Tarr
authors.forename: Horst G
authors.initials: HG
authors.lastname: Haack
authors.forename: Ferdinand
authors.initials: F
authors.lastname: Martius
authors.forename: Claudio
authors.initials: C
authors.lastname: Stoebe
authors.forename: Reno
authors.initials: R
authors.lastname: Frei
authors.forename: Juerg
authors.initials: J
authors.lastname: Danuser
authors.forename: Andreas W
authors.initials: AW
authors.lastname: Jehle
mesh_terms: D000368:Aged; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D002417:Cattle; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D000069285:Infliximab; D012008:Recurrence; D013557:Switzerland; D014380:Tuberculosis, Bovine / Q000139:chemically induced*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab